COVID-19 Treatment

• Ontario pharmacists allowed to prescribe Paxlovid for COVID-19 treatment

  Ontario's health minister Sylvia Jones said pharmacists can prescribe Paxlovid to treat severe cases of COVID-19 at no cost to the patient starting on Monday, Dec. 12.

  Health

  Dec 8, 2022
  
• Alberta awaiting further ‘guidance’ on Health Canada-approved COVID-19 treatment

  Evusheld is currently only available in Alberta for the prevention of COVID-19 but was also recently approved as a treatment.

  Canada

  Oct 25, 2022
  
• Advertisement
• Approval of AstraZeneca’s Evusheld COVID treatment in Canada is ‘good news,’ experts say

  AstraZeneca Canada said in a press release that its Evusheld has received a Notice of Compliance from Health Canada to treat COVID-19 for those aged 12 or older.

  Health

  Oct 19, 2022
• Advertisement
• U.S. gives full approval to 1st COVID-19 drug for young children

  The U.S. drug regulator on Monday granted the first full approval for treating COVID-19 in children aged 28 days and older to Gilead Sciences Inc's GILD.O drug remdesivir.

  Health

  Apr 25, 2022
• COVID-19 treatment sotrovimab unlikely to protect against BA.2: Health Canada

  Canada's federal drug regulator issued a notice to health-care professionals on Thursday indicating that sotrovimab will not likely work against the BA.2 variant.

  Canada

  Apr 15, 2022
• FDA authorizes new antibody drug that targets Omicron COVID-19 variant

  The Food and Drug Administration said it cleared the Eli Lilly drug for adults and adolescent patients with mild-to-moderate cases of COVID-19.

  World

  Feb 11, 2022
• COVID-19 pill will be available to thousands in Britain in February

  Britain's health ministry said that Pfizer's antiviral treatment Paxlovid will be made available to thousands of people beginning Feb. 10.

  World

  Jan 28, 2022
• Paxlovid pills set to arrive in Saskatchewan this week

  The province stressed the availability of the novel treatments will be limited and that they are not a substitute for getting vaccinated.

  Canada

  Jan 18, 2022
• Advertisement
• Pfizer’s antiviral COVID-19 pill approved by U.K. regulators

  Pfizer this month said Paxlovid showed near 90 per cent efficacy in preventing hospitalizations and deaths in high-risk COVID-19 patients.

  World

  Dec 31, 2021
• Advertisement
• FDA approves 1st COVID-19 antibody drug intended for long-term prevention

  People who could benefit from the antibody drug include cancer patients, organ transplant recipients and people taking immune-suppressing drugs.

  World

  Dec 8, 2021